ArticleCureus2025
A Cross-Sectional Study on Client Satisfaction of Opioid Substitution Therapy (OST) in a Tertiary Care Hospital of Punjab, India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOpioid substitution therapy (OST) program under the National Aids Control Organization (NACO), India, is a harm-reduction approach targeting injectable opioid use. However, this 'one-size-fits-all' approach may potentially deter client satisfaction. Scant data on service quality in India warranted the current research.
methodsThis was a cross-sectional study in one OST center at a tertiary-care hospital in Punjab, India. Socio-demographic details of registered OST clients were collected. Client satisfaction was assessed using the GGZ (Geestelijke Gezondheidszorg; Dutch: mental healthcare) Thermometer.
resultsA total of 142 clients participated. Mean quality score was 7.6±1.5 (satisfactory). Positive rating was given by 93.7%, 46.5%, 61.3%, and 97.2% of clients for information, decision making, care provider, and treatment result domains, respectively. An open question regarding quality revealed 'requirement of advanced doses' by 24.6% and 'difficulty in daily visits' by 11.3%. GGZ score negatively correlated with current buprenorphine+naloxone (BPN) dose (r=-0.17, p=0.046). Those with a <6 score had a longer duration on OST (p=0.011), which positively correlated with starting BPN dose (r=0.43, p<0.001).
conclusionIt was concluded that the center performed satisfactorily at providing information and treatment results, but lacked in client participation and caregiver standards. Individual tailoring of treatment and enhancing on-site psychosocial support is needed to improve quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.